Frank X Leonard $NVCR SEC Form 4 Insider Trading

Frank X Leonard has filed a total of 52 insider trades in $NVCR since 2021. Their most recent trade was a sale of 2,770 shares, made on Feb 28, 2025. Their largest trade was a sale of 10,277 shares, made on Feb 27, 2025. We estimate that they now own 198,648 shares of $NVCR, worth an estimated $3.5 million.

Insider Trading at $NVCR

There have been a total of 167 insider trades reported at $NVCR since 2021, with 4,974 shares purchased and 582,131 shares sold. The most active insider traders in $NVCR stock have been Frank X Leonard, Frank X Leonard, and Ashley Cordova. The most recent trade was a sale of 311 shares reported by Uri Weinberg (Chief Innovation Officer), made on Feb 28, 2025.

$NVCR Executives and Stock Owners with Insider Trades

• Frank X Leonard, Chief Development Officer

• Frank X Leonard, President, CNS Cancers US

• Ashley Cordova, Chief Financial Officer

• Asaf Danziger, Chief Executive Officer

• Wilhelmus Cm Groenhuysen, Chief Operating Officer

• Pritesh Shah, Chief Commercial Officer

• William Patrick Burke, Chief Human Resources Officer

• Ely Benaim, Chief Medical Officer

• Frank X Leonard, EVP, Pres., Novocure Oncology

• Pritesh Shah, Chief Growth Officer

• Mukund Paravasthu, Chief Operating Officer

• Uri Weinberg, Chief Science Officer

• Michal Nath Puri, Chief Human Resources Officer

• Ashley Cordova, Chief Executive Officer

• Todd Christopher Longsworth, General Counsel

• William F Doyle, Executive Chairman

• Uri Weinberg, Chief Innovation Officer

• Nicolas Leupin, Chief Medical Officer

*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.